Biological

Ended Awarded Last action

Contract number
75N91023F00013
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$24,258
Original award $24,258

About this award

The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a Blanket Purchase Agreement Call contract to 10X Genomics, Inc. of Pleasanton, California. With a completion date of December 26, 2023 and awarded on September 8, 2023, this firm fixed price contract has a potential value of $0.00. No set-aside designation was used. As a leading provider of solutions for single-cell analysis, 10X Genomics will likely support the NCI's cancer research efforts through delivery of its genomic platforms and assays over the term of the BPA Call contract.

Quick answers

Who was awarded contract 75N91023F00013?

75N91023F00013 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on September 8, 2023.

How much is contract 75N91023F00013 worth?

The government has obligated $0 on 75N91023F00013.

Is contract 75N91023F00013 an order under another contract?

Yes. 75N91023F00013 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N91023F00013 competed?

The extent of competition for 75N91023F00013 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award